Korea's Fair Trade Commission Looking Into Allegations That MNCs Offered Kickbacks To Block New Generic Entrants
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The South Korean government's fair trade watchdog - the Fair Trade Commission - is investigating reports of "reverse payments" or kickbacks offered to local Korean generic drug makers by multinational pharmaceutical companies to keep generics off the market after patents expire on an original drug